Background
Opioid receptors are widely distributed in brain, spinal cord and peripheral sensory and autonomic nerves. They are activated physiologically by the products of endogenous opioid peptide genes such as proenkephalin, podynorphin, pro-opiomelancortin and pronociceptin. Four opioid receptor subtypes have been identified including µ, δ, κ, and ORL1. All of these subtypes are coupled to cAMP modulation via Gi/o but each subtype has a distinct pharmacological profile.
| General Info | |
| Synonyms | OPRL1 |
|---|---|
| Product Description | Human ORL1 Opioid Receptor-expressing GPCR (G protein-coupled receptor) stable, replicating cell line. |
| Target Type | GPCR |
| Product Type | Replicating Cell Line |
| Receptor | Opioid |
| Sub-Type | ORL1 |
| Therapeutic Area | metabolic & gastrointestinal, pain & inflammation, psychiatric disorder |
| Related Services | Membrane Preparation, Large-scale Cryopreservation |
| Genbank Accession Number | NM_000913 |
| Validated Assay/Platform | cAMP |
| References | Dhawan, B. et al., International Union of Pharmacology. XIII. Classification of Opioid Receptors. Pharmacol. Rev. 48: 567-592 (1996). |
| Host cell | CHO-K1 |
| Mycoplasma Status | Negative (MycoAlert Kit) |
| Growth media | Ham's F12, 10% FBS, 1% NEAA, 0.4 mg/mL G418 |
| Storage & Packaging | |
| Packaging | Cryopreserved cells, 6 million cells per vial |
| Storage Recommendation | liquid nitrogen |
| Stability | 12 passages (6 weeks of continuous culture) |
| Quantity | 6 million cells |
| Product Documentation | |
| Specification Sheet | |



